tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PFE Stock Latest News

Pfizer’s Migraine Study: Real-World Insights on Nurtec vs. Triptans
Company AnnouncementsPfizer’s Migraine Study: Real-World Insights on Nurtec vs. Triptans
7h ago
PFE
Pfizer’s Latest Study on NSCLC Treatment: A Potential Game-Changer?
PremiumCompany Announcements
Pfizer’s Latest Study on NSCLC Treatment: A Potential Game-Changer?
2d ago
PFE
Enanta files EU patent infringement suit against Pfizer
PremiumThe Fly
Enanta files EU patent infringement suit against Pfizer
3d ago
PFE
ENTA
Why Pfizer’s (PFE) Oncology Gamble is Finally Paying Off
PremiumMarket News
Why Pfizer’s (PFE) Oncology Gamble is Finally Paying Off
3d ago
PFE
Moderately bullish activity in Pfizer with shares up 1.3%
PremiumThe Fly
Moderately bullish activity in Pfizer with shares up 1.3%
3d ago
PFE
Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine
PremiumThe FlyPfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine
4d ago
PFE
BNTX
Mixed options sentiment in Pfizer with shareslittle changed
Premium
The Fly
Mixed options sentiment in Pfizer with shareslittle changed
4d ago
PFE
This Activist Investor Ramped Up Salesforce (NYSE:CRM) Stake by 50% in Q2
Premium
Market News
This Activist Investor Ramped Up Salesforce (NYSE:CRM) Stake by 50% in Q2
7d ago
CRM
IWM
Pfizer’s (PFE) Sickle Cell Drug Fails to Meet Its Main Goal
PremiumMarket News
Pfizer’s (PFE) Sickle Cell Drug Fails to Meet Its Main Goal
7d ago
PFE
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
PremiumThe Fly
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
7d ago
AMD
AZN
Pfizer’s Promising Study on PF-07248144: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Pfizer’s Promising Study on PF-07248144: A Potential Game-Changer in Cancer Treatment
7d ago
PFE
Pfizer’s Latest Study on HER2-positive Breast Cancer: Key Insights for Investors
PremiumCompany Announcements
Pfizer’s Latest Study on HER2-positive Breast Cancer: Key Insights for Investors
7d ago
PFE
Pfizer’s New Cancer Treatment Study: A Potential Game Changer?
PremiumCompany AnnouncementsPfizer’s New Cancer Treatment Study: A Potential Game Changer?
7d ago
PFE
Pfizer’s New Study on Eczema Treatment: What Investors Need to Know
Premium
Company Announcements
Pfizer’s New Study on Eczema Treatment: What Investors Need to Know
7d ago
PFE
Pfizer’s Latest Clinical Trial: A New Hope for KRAS-Mutated Tumors
Premium
Company Announcements
Pfizer’s Latest Clinical Trial: A New Hope for KRAS-Mutated Tumors
7d ago
PFE
Pfizer’s Tukysa Study: A Closer Look at Its Korean Market Impact
PremiumCompany Announcements
Pfizer’s Tukysa Study: A Closer Look at Its Korean Market Impact
7d ago
PFE
Pfizer’s PREVENAR 20 Vaccine Study: A Safety Investigation in Infants
PremiumCompany Announcements
Pfizer’s PREVENAR 20 Vaccine Study: A Safety Investigation in Infants
7d ago
PFE
Pfizer’s New Study on Disitamab Vedotin: A Potential Game-Changer in Advanced Breast Cancer Treatment
PremiumCompany Announcements
Pfizer’s New Study on Disitamab Vedotin: A Potential Game-Changer in Advanced Breast Cancer Treatment
7d ago
PFE
Pfizer’s Real-World Study on Abrocitinib: Implications for Investors
PremiumCompany Announcements
Pfizer’s Real-World Study on Abrocitinib: Implications for Investors
7d ago
PFE
Pfizer’s Phase 1 Study on PF-08046031: A New Hope for Advanced Melanoma and Solid Tumors
PremiumCompany AnnouncementsPfizer’s Phase 1 Study on PF-08046031: A New Hope for Advanced Melanoma and Solid Tumors
7d ago
PFE
Pfizer’s Abrocitinib Study: Real-World Insights into Atopic Dermatitis Treatment
Premium
Company Announcements
Pfizer’s Abrocitinib Study: Real-World Insights into Atopic Dermatitis Treatment
7d ago
PFE
Pfizer’s Promising Phase 3 Study on Ritlecitinib for Vitiligo: A Potential Game-Changer
Premium
Company Announcements
Pfizer’s Promising Phase 3 Study on Ritlecitinib for Vitiligo: A Potential Game-Changer
7d ago
PFE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >